|
Yoga: Effect on Attention in Aging & Multiple Sclerosis Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Yoga: Effect on Attention in Aging & Multiple Sclerosis conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Yoga: Effect on Attention in Aging & Multiple Sclerosis Clinical research trials and Yoga: Effect on Attention in Aging & Multiple Sclerosis health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Yoga: Effect on Attention in Aging & Multiple Sclerosis. Yoga: Effect on Attention in Aging & Multiple Sclerosis Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Yoga: Effect on Attention in Aging & Multiple Sclerosis clinical trial. Subjects frequently get the best healthcare possible for their Yoga: Effect on Attention in Aging & Multiple Sclerosis condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "Y" Clinical Trials Conditions > Yoga: Effect on Attention in Aging & Multiple Sclerosis  Yoga: Effect on Attention in Aging & Multiple Sclerosis
Yoga: Effect on Attention in Aging & Multiple Sclerosis
For Condition: Multiple Sclerosis
Status: No longer recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: Changes in visual attention are common among elders and people with multiple sclerosis. The visual attention changes contribute to difficulty with day to day functioning including falls, driving and even finding one's keys on the kitchen counter as well as contributing to deficits in other cognitive domains. Yoga emphasizes the ability to focus attention and there is some evidence that the practice of yoga may improve one's cognitive abilities. Additionally, yoga practice may improve cognitive function through other non-specific means such as improved mood, decreased stress or declines in oxidative injury. We propose a randomized, controlled 6 month phase II trial of yoga in two separate cohorts: healthy elders and subjects with mild multiple sclerosis. We will determine if yoga intervention produces improvements on a broad attentional battery that especially emphasizes attentional control. To further understand the reported beneficial effect of yoga on its practitioners, we will also determine if there is a positive impact on measures directly related to yoga practice (flexibility and balance) as well as mood, quality of life and oxidative injury markers. The yoga intervention consists of a Hatha yoga class meeting twice per week. The class is taught by experienced yoga teachers who are supervised by a nationally known yoga instructor. There are two control groups. An exercise group will have a structured walking program prescribed by a certified Health and Fitness Instructor and Personal Trainer. The program will attempt to match the Hatha yoga class for metabolic demand. The second control group will be assigned to a 6 month waiting list. The outcome measures are assessed at baseline and after the 6 month period. The primary outcome measures are alertness (quantitative EEG and self-rated scale), ability to focus attention (Stroop) and ability to shift attention (extradimensional set shifting task). Secondary attention outcome measures include the ability to sustain attention (decrement in reaction time) and ability to divide attention (Useful Field of View). Other secondary outcome measures include flexibility, balance, mood, quality of life, fatigue (in MS cohort) and decreased markers of lipid, protein, and DNA oxidative injury.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 65 Years/85 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Patients with MS who are mildly impaired with an expanded disability status scale of 0-4.0 - Healthy volunteers
Total Enrollment:
Location and Contact Information:
Overall Study Official:
Dr.S. Oken, Principal Investigator, Oregon Health and Science University
Oregon Health Sciences University/Neurology
Portland, Oregon, 97201
United States
Additional Information:
Study ID Numbers: 1 P50 AT00066-01P3; 1 P50 AT00066-01
Study Start Date:
Record last reviewed: August 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00010998
Other Multiple Sclerosis Studies:
1. Assessment of Patients with Multiple Sclerosis (MS)
2. Improving Memory in Patients with Multiple Sclerosis
3. Induction Therapy with a Single High Dose Bolus of Intravenous Methotrexate with Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting with a First Acute Demyelinating Event.
4. Safety, Tolerability, and Effectiveness of CGP77116 in Patients with Multiple Sclerosis (MS)
5. Safety of RG2077 in Patients With Multiple Sclerosis
Related Studies:
Other Multiple Sclerosis Clinical Trials
Other Oregon Clinical Trials
Other Portland Clinical Trials
Yoga: Effect on Attention in Aging & Multiple Sclerosis
|
|
|
|
|
|
|
|
